Literature DB >> 12112730

Neuropathology of Rett syndrome.

Dawna Duncan Armstrong1.   

Abstract

Rett Syndrome is unlike any other pediatric neurologic disease, and its clinical-pathologic correlation can not be defined with standard histology techniques. Based on hypotheses suggested by careful clinical observations, the nervous system of the Rett child has been explored utilizing morphometry, golgi preparations, computerized tomography, magnetic resonance imaging, chemistry, immunocytochemistry, autoradiography, and molecular biologic techniques. From these many perspectives we conclude that Rett syndrome is not a typical degenerative disorder, storage disorder, nor the result of gross malformation, infectious or neoplastic processes. There remain regions of the brain that have not been studied in detail but the available data suggest that the neuropathology of Rett syndrome can be summarized as follows: the Rett brain is small for the age and the height of the patient; it does not become progressively smaller over three to four decades; it has small dendritic trees in pyramidal neurons of layers III and V in selected lobes (frontal, motor, and temporal); it has small neurons with an increased neuronal packing density; it has an immature expression of microtubular protein-2 and cyclooxygenase; it exhibits a changing pattern of neurotransmitter receptors with an apparent reduction in many neurotransmitters, possibly contributing to some symptomatology. A mutation in Mecp2 causes this unique disorder of brain development. Neuronal mosaicism for normal and mutated Mecp2 produces a consistent phenotype in the classic female patient and a small brain with some preserved islands of function, but with an inability to support hand use and speech. This paper summarizes our current observations about neuropathology of Rett syndrome. MRDD Research Reviews 2002;8:72-76. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112730     DOI: 10.1002/mrdd.10027

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  31 in total

Review 1.  The role of MeCP2 in CNS development and function.

Authors:  Elisa S Na; Lisa M Monteggia
Journal:  Horm Behav       Date:  2010-05-31       Impact factor: 3.587

Review 2.  Experimental models of Rett syndrome based on Mecp2 dysfunction.

Authors:  Gaston Calfa; Alan K Percy; Lucas Pozzo-Miller
Journal:  Exp Biol Med (Maywood)       Date:  2011-01

3.  Epigenetic regulation of neuronal dendrite and dendritic spine development.

Authors:  Richard D Smrt; Xinyu Zhao
Journal:  Front Biol (Beijing)       Date:  2010-08

4.  Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function.

Authors:  Sonia Cohen; Harrison W Gabel; Martin Hemberg; Ashley N Hutchinson; L Amanda Sadacca; Daniel H Ebert; David A Harmin; Rachel S Greenberg; Vanessa K Verdine; Zhaolan Zhou; William C Wetsel; Anne E West; Michael E Greenberg
Journal:  Neuron       Date:  2011-10-06       Impact factor: 17.173

5.  Ocular MECP2 protein expression in patients with and without Rett syndrome.

Authors:  Deepali Jain; Kamaljeet Singh; Sankar Chirumamilla; Genila M Bibat; Mary E Blue; Sakkubai R Naidu; Charles G Eberhart
Journal:  Pediatr Neurol       Date:  2010-07       Impact factor: 3.372

Review 6.  Child and adolescent psychiatric genetics.

Authors:  Johannes Hebebrand; Andre Scherag; Benno G Schimmelmann; Anke Hinney
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-02-06       Impact factor: 4.785

7.  Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome.

Authors:  Skirmantas Kriaucionis; Andrew Paterson; John Curtis; Jacky Guy; Nikki Macleod; Adrian Bird
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

8.  Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations.

Authors:  Jennifer L Larimore; Christopher A Chapleau; Shinichi Kudo; Anne Theibert; Alan K Percy; Lucas Pozzo-Miller
Journal:  Neurobiol Dis       Date:  2009-01-03       Impact factor: 5.996

9.  CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail.

Authors:  Laura Rusconi; Lisa Salvatoni; Laura Giudici; Ilaria Bertani; Charlotte Kilstrup-Nielsen; Vania Broccoli; Nicoletta Landsberger
Journal:  J Biol Chem       Date:  2008-08-13       Impact factor: 5.157

10.  Selective cerebral volume reduction in Rett syndrome: a multiple-approach MR imaging study.

Authors:  J C Carter; D C Lanham; D Pham; G Bibat; S Naidu; W E Kaufmann
Journal:  AJNR Am J Neuroradiol       Date:  2007-12-07       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.